Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 265 entries
Sorted by: Best Match Show Resources per page
Anaesthesia and larygomalacia.

Journal of anaesthesiology, clinical pharmacology

Gupta A, Bathla S, Kamal G, Saini S.
PMID: 21804728
J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):128-9.

No abstract available.

Cite
Gupta A, Bathla S, Kamal G, et al. Anaesthesia and larygomalacia. J Anaesthesiol Clin Pharmacol. 2011;27(1):128-9
Gupta, A., Bathla, S., Kamal, G., & Saini, S. (2011). Anaesthesia and larygomalacia. Journal of anaesthesiology, clinical pharmacology, 27(1), 128-9.
Gupta, Aikta, et al. "Anaesthesia and larygomalacia." Journal of anaesthesiology, clinical pharmacology vol. 27,1 (2011): 128-9.
Gupta A, Bathla S, Kamal G, Saini S. Anaesthesia and larygomalacia. J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):128-9. PMID: 21804728; PMCID: PMC3146136.
Copy Download .nbib Format: NLM
Antibacterial Efficacy of Several Surgical Hand Preparation Products Used by Veterinary Students.

Veterinary surgery : VS

Verwilghen D, Kampf G, Doyle AJ.
PMID: 27706819
Vet Surg. 2016 Nov;45(8):1118-1119. doi: 10.1111/vsu.12566. Epub 2016 Oct 05.

No abstract available.

Cite
Verwilghen D, Kampf G, Doyle AJ. Antibacterial Efficacy of Several Surgical Hand Preparation Products Used by Veterinary Students. Vet Surg. 2016;45(8):1118-1119doi: 10.1111/vsu.12566.
Verwilghen, D., Kampf, G., & Doyle, A. J. (2016). Antibacterial Efficacy of Several Surgical Hand Preparation Products Used by Veterinary Students. Veterinary surgery : VS, 45(8), 1118-1119. https://doi.org/10.1111/vsu.12566
Verwilghen, Denis, et al. "Antibacterial Efficacy of Several Surgical Hand Preparation Products Used by Veterinary Students." Veterinary surgery : VS vol. 45,8 (2016): 1118-1119. doi: https://doi.org/10.1111/vsu.12566
Verwilghen D, Kampf G, Doyle AJ. Antibacterial Efficacy of Several Surgical Hand Preparation Products Used by Veterinary Students. Vet Surg. 2016 Nov;45(8):1118-1119. doi: 10.1111/vsu.12566. Epub 2016 Oct 05. PMID: 27706819.
Copy Download .nbib Format: NLM
Black Box Oxidizers.

Infection control and hospital epidemiology

Kampf G.
PMID: 28946928
Infect Control Hosp Epidemiol. 2017 Nov;38(11):1387-1388. doi: 10.1017/ice.2017.199. Epub 2017 Sep 26.

No abstract available.

Cite
Kampf G. Black Box Oxidizers. Infect Control Hosp Epidemiol. 2017;38(11):1387-1388doi: 10.1017/ice.2017.199.
Kampf, G. (2017). Black Box Oxidizers. Infection control and hospital epidemiology, 38(11), 1387-1388. https://doi.org/10.1017/ice.2017.199
Kampf, Günter. "Black Box Oxidizers." Infection control and hospital epidemiology vol. 38,11 (2017): 1387-1388. doi: https://doi.org/10.1017/ice.2017.199
Kampf G. Black Box Oxidizers. Infect Control Hosp Epidemiol. 2017 Nov;38(11):1387-1388. doi: 10.1017/ice.2017.199. Epub 2017 Sep 26. PMID: 28946928.
Copy Download .nbib Format: NLM
Subclavian artery injury secondary to clavicular plate fixation: a novel operative approach.

Journal of surgical case reports

Perera KG, Clifford C, Maddock L.
PMID: 25877827
J Surg Case Rep. 2015 Apr 15;2015(4). doi: 10.1093/jscr/rjv044.

We present the case of a 32-year-old male with a delayed symptomatic left subclavian artery pseudoaneurysm secondary to protruding screws from prior perpendicular clavicular plate fixations. The pseudoaneurysm development and our operative approach are unique to the few similar...

Cite
Perera KG, Clifford C, Maddock L. Subclavian artery injury secondary to clavicular plate fixation: a novel operative approach. J Surg Case Rep. 2015;2015(4)doi: 10.1093/jscr/rjv044.
Perera, K. G., Clifford, C., & Maddock, L. (2015). Subclavian artery injury secondary to clavicular plate fixation: a novel operative approach. Journal of surgical case reports, 2015(4), . https://doi.org/10.1093/jscr/rjv044
Perera, Kalpa G, et al. "Subclavian artery injury secondary to clavicular plate fixation: a novel operative approach." Journal of surgical case reports vol. 2015,4 (2015). doi: https://doi.org/10.1093/jscr/rjv044
Perera KG, Clifford C, Maddock L. Subclavian artery injury secondary to clavicular plate fixation: a novel operative approach. J Surg Case Rep. 2015 Apr 15;2015(4). doi: 10.1093/jscr/rjv044. PMID: 25877827; PMCID: PMC4397720.
Copy Download .nbib Format: NLM
Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?.

Journal of pharmacology & pharmacotherapeutics

Gupta P, Kamal G, Gupta M.
PMID: 26816473
J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):211-3. doi: 10.4103/0976-500X.171873.

Malignant hyperpyrexia syndrome (MHS) is a rare entity and may not be encountered by the anaesthesiologists throughout their professional career. Whenever it manifests can be a challenging task to manage and prove to be fatal when a timely diagnosis...

Cite
Gupta P, Kamal G, Gupta M. Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?. J Pharmacol Pharmacother. 2015;6(4):211-3doi: 10.4103/0976-500X.171873.
Gupta, P., Kamal, G., & Gupta, M. (2015). Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?. Journal of pharmacology & pharmacotherapeutics, 6(4), 211-3. https://doi.org/10.4103/0976-500X.171873
Gupta, Priyanka, et al. "Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?." Journal of pharmacology & pharmacotherapeutics vol. 6,4 (2015): 211-3. doi: https://doi.org/10.4103/0976-500X.171873
Gupta P, Kamal G, Gupta M. Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?. J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):211-3. doi: 10.4103/0976-500X.171873. PMID: 26816473; PMCID: PMC4714388.
Copy Download .nbib Format: NLM
Challenges in the delivery of therapies to melanoma brain metastases.

Current pharmacology reports

Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF.
PMID: 28546917
Curr Pharmacol Rep. 2016 Dec;2(6):309-325. doi: 10.1007/s40495-016-0072-z. Epub 2016 Nov 09.

Brain metastases are a major cause of morbidity and mortality in patients with advanced melanoma. Recent approval of several molecularly-targeted agents and biologics has brought hope to patients with this previously untreatable disease. However, patients with symptomatic melanoma brain...

Cite
Gampa G, Vaidhyanathan S, Resman BW, et al. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep. 2016;2(6):309-325doi: 10.1007/s40495-016-0072-z.
Gampa, G., Vaidhyanathan, S., Resman, B. W., Parrish, K. E., Markovic, S. N., Sarkaria, J. N., & Elmquist, W. F. (2016). Challenges in the delivery of therapies to melanoma brain metastases. Current pharmacology reports, 2(6), 309-325. https://doi.org/10.1007/s40495-016-0072-z
Gampa, Gautham, et al. "Challenges in the delivery of therapies to melanoma brain metastases." Current pharmacology reports vol. 2,6 (2016): 309-325. doi: https://doi.org/10.1007/s40495-016-0072-z
Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep. 2016 Dec;2(6):309-325. doi: 10.1007/s40495-016-0072-z. Epub 2016 Nov 09. PMID: 28546917; PMCID: PMC5440090.
Copy Download .nbib Format: NLM
Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias.

Genes

Hebert E, Borngräber F, Schmidt A, Rakovic A, Brænne I, Weissbach A, Hampf J, Vollstedt EJ, Größer L, Schaake S, Müller M, Manzoor H, Jabusch HC, Alvarez-Fischer D, Kasten M, Kostic VS, Gasser T, Zeuner KE, Kim HJ, Jeon B, Bauer P, Altenmüller E, Klein C, Lohmann K.
PMID: 29057844
Genes (Basel). 2017 Oct 18;8(10). doi: 10.3390/genes8100276.

Mutations in RAB (member of the Ras superfamily) genes are increasingly recognized as cause of a variety of disorders including neurological conditions. While musician's dystonia (MD) and writer's dystonia (WD) are task-specific movement disorders, other dystonias persistently affect postures...

Cite
Hebert E, Borngräber F, Schmidt A, et al. Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias. Genes (Basel). 2017;8(10)doi: 10.3390/genes8100276.
Hebert, E., Borngräber, F., Schmidt, A., Rakovic, A., Brænne, I., Weissbach, A., Hampf, J., Vollstedt, E. J., Größer, L., Schaake, S., Müller, M., Manzoor, H., Jabusch, H. C., Alvarez-Fischer, D., Kasten, M., Kostic, V. S., Gasser, T., Zeuner, K. E., Kim, H. J., Jeon, B., Bauer, P., Altenmüller, E., Klein, C., & Lohmann, K. (2017). Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias. Genes, 8(10), . https://doi.org/10.3390/genes8100276
Hebert, Eva, et al. "Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias." Genes vol. 8,10 (2017). doi: https://doi.org/10.3390/genes8100276
Hebert E, Borngräber F, Schmidt A, Rakovic A, Brænne I, Weissbach A, Hampf J, Vollstedt EJ, Größer L, Schaake S, Müller M, Manzoor H, Jabusch HC, Alvarez-Fischer D, Kasten M, Kostic VS, Gasser T, Zeuner KE, Kim HJ, Jeon B, Bauer P, Altenmüller E, Klein C, Lohmann K. Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias. Genes (Basel). 2017 Oct 18;8(10). doi: 10.3390/genes8100276. PMID: 29057844; PMCID: PMC5664126.
Copy Download .nbib Format: NLM
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials.

Journal of thoracic disease

Pavasini R, Serenelli M, Gallo F, Bugani G, Geraci S, Vicinelli P, Campo G.
PMID: 28894594
J Thorac Dis. 2017 Aug;9:S887-S897. doi: 10.21037/jtd.2017.06.59.

BACKGROUND: In the last years bioresorbable vascular scaffold (BVS) become a new therapeutic option for interventional cardiologists, with the advantage of a scaffold inducing a possible vessel wall restoration. Nevertheless, several trials tried to prove the safety and efficacy...

Cite
Pavasini R, Serenelli M, Gallo F, et al. Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials. J Thorac Dis. 2017;9:S887-S897doi: 10.21037/jtd.2017.06.59.
Pavasini, R., Serenelli, M., Gallo, F., Bugani, G., Geraci, S., Vicinelli, P., & Campo, G. (2017). Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials. Journal of thoracic disease, 9S887-S897. https://doi.org/10.21037/jtd.2017.06.59
Pavasini, Rita, et al. "Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials." Journal of thoracic disease vol. 9 (2017): S887-S897. doi: https://doi.org/10.21037/jtd.2017.06.59
Pavasini R, Serenelli M, Gallo F, Bugani G, Geraci S, Vicinelli P, Campo G. Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials. J Thorac Dis. 2017 Aug;9:S887-S897. doi: 10.21037/jtd.2017.06.59. PMID: 28894594; PMCID: PMC5583087.
Copy Download .nbib Format: NLM
The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey.

Journal of thoracic disease

Serenelli M, Biscaglia S, Tonet E, Poli A, Nicolini E, Ielasi A, Erriquez A, Campo G.
PMID: 28894595
J Thorac Dis. 2017 Aug;9:S898-S902. doi: 10.21037/jtd.2017.06.111.

BACKGROUND: To evaluate how the 3-year results from the "A clinical evaluation to compare the safety, efficacy and performance of ABSORB everolimus eluting bioresorbable vascular scaffold (BVS) system against XIENCE everolimus eluting coronary stent system in the treatment of...

Cite
Serenelli M, Biscaglia S, Tonet E, et al. The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey. J Thorac Dis. 2017;9:S898-S902doi: 10.21037/jtd.2017.06.111.
Serenelli, M., Biscaglia, S., Tonet, E., Poli, A., Nicolini, E., Ielasi, A., Erriquez, A., & Campo, G. (2017). The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey. Journal of thoracic disease, 9S898-S902. https://doi.org/10.21037/jtd.2017.06.111
Serenelli, Matteo, et al. "The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey." Journal of thoracic disease vol. 9 (2017): S898-S902. doi: https://doi.org/10.21037/jtd.2017.06.111
Serenelli M, Biscaglia S, Tonet E, Poli A, Nicolini E, Ielasi A, Erriquez A, Campo G. The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey. J Thorac Dis. 2017 Aug;9:S898-S902. doi: 10.21037/jtd.2017.06.111. PMID: 28894595; PMCID: PMC5583080.
Copy Download .nbib Format: NLM
Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes.

Cell reports

Väremo L, Scheele C, Broholm C, Mardinoglu A, Kampf C, Asplund A, Nookaew I, Uhlén M, Pedersen BK, Nielsen J.
PMID: 28954239
Cell Rep. 2016 Feb 16;14(6):1567. doi: 10.1016/j.celrep.2016.01.054. Epub 2016 Feb 16.

No abstract available.

Cite
Väremo L, Scheele C, Broholm C, et al. Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes. Cell Rep. 2016;14(6):1567doi: 10.1016/j.celrep.2016.01.054.
Väremo, L., Scheele, C., Broholm, C., Mardinoglu, A., Kampf, C., Asplund, A., Nookaew, I., Uhlén, M., Pedersen, B. K., & Nielsen, J. (2016). Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes. Cell reports, 14(6), 1567. https://doi.org/10.1016/j.celrep.2016.01.054
Väremo, Leif, et al. "Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes." Cell reports vol. 14,6 (2016): 1567. doi: https://doi.org/10.1016/j.celrep.2016.01.054
Väremo L, Scheele C, Broholm C, Mardinoglu A, Kampf C, Asplund A, Nookaew I, Uhlén M, Pedersen BK, Nielsen J. Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes. Cell Rep. 2016 Feb 16;14(6):1567. doi: 10.1016/j.celrep.2016.01.054. Epub 2016 Feb 16. PMID: 28954239.
Copy Download .nbib Format: NLM
Fractional flow reserve implementation in daily clinical practice: A European survey.

International journal of cardiology

Tebaldi M, Biscaglia S, Pecoraro A, Fineschi M, Campo G.
PMID: 26803245
Int J Cardiol. 2016 Mar 15;207:206-7. doi: 10.1016/j.ijcard.2016.01.097. Epub 2016 Jan 09.

No abstract available.

Cite
Tebaldi M, Biscaglia S, Pecoraro A, et al. Fractional flow reserve implementation in daily clinical practice: A European survey. Int J Cardiol. 2016;207:206-7doi: 10.1016/j.ijcard.2016.01.097.
Tebaldi, M., Biscaglia, S., Pecoraro, A., Fineschi, M., & Campo, G. (2016). Fractional flow reserve implementation in daily clinical practice: A European survey. International journal of cardiology, 207206-7. https://doi.org/10.1016/j.ijcard.2016.01.097
Tebaldi, Matteo, et al. "Fractional flow reserve implementation in daily clinical practice: A European survey." International journal of cardiology vol. 207 (2016): 206-7. doi: https://doi.org/10.1016/j.ijcard.2016.01.097
Tebaldi M, Biscaglia S, Pecoraro A, Fineschi M, Campo G. Fractional flow reserve implementation in daily clinical practice: A European survey. Int J Cardiol. 2016 Mar 15;207:206-7. doi: 10.1016/j.ijcard.2016.01.097. Epub 2016 Jan 09. PMID: 26803245.
Copy Download .nbib Format: NLM
CONCENTRATION OF MICROFILARIAE BY THE SALIVARY SECRETIONS OF BLOODSUCKING INSECTS.

Science (New York, N.Y.)

Dampf A.
PMID: 17789583
Science. 1933 Jan 06;77(1984):20-1. doi: 10.1126/science.77.1984.20-a.

No abstract available.

Cite
Dampf A. CONCENTRATION OF MICROFILARIAE BY THE SALIVARY SECRETIONS OF BLOODSUCKING INSECTS. Science. 1933;77(1984):20-1doi: 10.1126/science.77.1984.20-a.
Dampf, A. (1933). CONCENTRATION OF MICROFILARIAE BY THE SALIVARY SECRETIONS OF BLOODSUCKING INSECTS. Science (New York, N.Y.), 77(1984), 20-1. https://doi.org/10.1126/science.77.1984.20-a
Dampf, A. "CONCENTRATION OF MICROFILARIAE BY THE SALIVARY SECRETIONS OF BLOODSUCKING INSECTS." Science (New York, N.Y.) vol. 77,1984 (1933): 20-1. doi: https://doi.org/10.1126/science.77.1984.20-a
Dampf A. CONCENTRATION OF MICROFILARIAE BY THE SALIVARY SECRETIONS OF BLOODSUCKING INSECTS. Science. 1933 Jan 06;77(1984):20-1. doi: 10.1126/science.77.1984.20-a. PMID: 17789583.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 265 entries